Neuropsychiatric Comorbidities in Dementia

Neuropsychiatric comorbidities in dementia, including symptoms like depression, anxiety, agitation, and psychosis, significantly impact patient outcomes and caregiver burden. These behavioral and psychological symptoms of dementia (BPSD) often complicate diagnosis and treatment, reducing quality of life. Understanding the neurobiological mechanisms behind these comorbidities is essential for developing targeted therapeutic strategies. Early identification and management of neuropsychiatric symptoms improve prognosis and delay disease progression. Integrating pharmacological and non-pharmacological interventions offers a holistic approach. Research in dementia-associated neuropsychiatric disorders remains a critical focus to enhance patient-centered care and optimize clinical outcomes in neurodegenerative diseases.

    Related Conference of Neuropsychiatric Comorbidities in Dementia

    September 23-24, 2026

    6th Annual Congress on Mental Health

    Amsterdam, Netherlands
    October 19-20, 2026

    6thAnnual Congress on Mental Health & Psychiatry

    Paris, France
    October 26-27, 2026

    6th Annual Psychiatrists and Psychologists Meet

    Amsterdam, Netherlands
    October 26-27, 2026

    International Congress on Cognitive Psychotherapy

    Amsterdam, Netherlands
    January 28-29, 2027

    9th International Congress on Mental Health

    Singapore City, Singapore
    March 18-19, 2027

    34th World Psychiatrists and Psychologists Meet

    Berlin, Germany
    March 25-26, 2027

    8th Annual Congress on Psychiatry

    Paris, France
    May 19-20, 2027

    9th European Autism Congress

    Paris, France
    September 14-15, 2027

    5th World Congress on Psychiatry

    London, UK

    Neuropsychiatric Comorbidities in Dementia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in